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Background: Chordomas are rare malignant tumors that are difﬁcult to treat and have high recurrence rates
despite aggressive therapy.
Objectives:We present the ﬁrst case of a patient with a clival chordoma in which complete tumor ablation was
achieved using Magnetic Resonance guided Laser Induced Thermal Therapy (LITT) delivered via an
endoscopic endonasal approach. We analyzed the safety and feasibility of this approach and quantiﬁed the
response of this pathology to thermal energy. This novel technique is intended to provide chordoma patients
with an alternative to surgery and radiotherapy.
Methods: A 54 year-old female with a newly diagnosed clival chordoma elected MRI- guided LITT. She
underwent placement of the laser catheter into the chordoma via an endoscopic endonasal approach. With
real-time MR thermometry monitoring, laser-generated thermal energy was delivered to the tumor. We
deﬁned several parameters to quantify the thermal ablation response: the thermal damage ratio and the
thermal ablation constant.
Results: Post procedure contrast-enhanced MRI demonstrated a complete thermal ablation of the mass. The
patient tolerated the procedure well and is being followedwith serial imaging. The tumor continues to regress
beyond 4 months. Additionally, chordoma cells seem to be sensitive to LITT, as indicated by a complete
ablation in less than 60 s.
Conclusion: The endoscopic endonasal approach to MRI-guided laser ablation is both technically feasible and
safe. As a result, this therapy may be a useful alternative in hard-to-reach chordomas, or in recurrent cases
that have failed other conventional treatment modalities.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Chordomas are rare, slow-growing, locally-invasive tumors occur-
ring mostly at the sacrococcygeal region and spheno-occipital
junction [1]. Treatment typically consists of en bloc surgical resection
with adjuvant radiation therapy. Despite such aggressive treatment,
the recurrence-free 5-year survival rate in patients with a skull base
chordoma is only 60–70% [2]. In recent years, advances in endoscopic
endonasal skull base surgery have allowed more complete surgical
resections with reduced morbidity.
One such method employs the use of thermal energy in treating
intracranial malignancies and has been achieved with radio waves,
ultrasound, microwaves, and lasers. Laser thermal ablation has been
successfully used in treating a variety of tumors outside the nervous
system [3] by destroying tumor cells within a well-deﬁned tissue
volume while sparing healthy peripheral tissue.linical Academic Building, 125
1962. Tel.: +1 732 235 7757;
anish).
B.V. This is an open access article uHowever, theunpredictabilityof the ablation size andvolumeaswell
as the irregular heating pattern and distribution has largely limited the
application of laser thermal ablation for intracranial lesions. The
development of magnetic resonance (MR) thermometry has recently
made it possible to target abnormal tissue and limit the amount of heat
distributed to surrounding tissues by acquiring real-time thermal
information during the procedure [4]. By combining these two
techniques, MRI-guided Laser Induced Thermal Therapy (LITT) is a
minimally-invasive method for delivering thermal energy delivered
through a ﬁber optic laser under stereotactic guidance and real-time
thermal feedback. The use of LITT in neurosurgery is gaining popularity
due to the ability to apply precise amounts of thermal energy to target
lesions that are difﬁcult or impossible to access with standard surgical
techniques. We present the ﬁrst application of MRI- guided LITT to a
clival chordoma, report short-termradiographic follow-up, anddescribe
ablation dynamics with respect to chordoma cells.Patients and methods
The patient is a 54 year-old female with several months of
progressive dysphagia and changes in her voice. As part of hernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Pre-treatment MRI. (A) Axial, (B) coronal, and (C) sagittal T1-weighted MRI with contrast showing the clival lesion (white arrows) protruding into the nasopharynx. The
lesion measures 1.8 cm × 1.35 cm × 1.3 cm at its widest diameters.
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MRI with gadolinium contrast showed a 1.8 × 1.35 × 1.3 cm well-
circumscribed, heterogeneously enhancing mass arising from the
ventral surface of the clivus and extending anteriorly into the
posterior nasopharynx (Fig. 1). There was mild T2 signal hyperinten-
sity within the lesion and no signiﬁcant FLAIR signal in the
surrounding tissue. A CT-guided needle biopsy established the
diagnosis of chordoma. She was referred for neurosurgical evaluation
and treatment. Further radiographic evaluations revealed that the
posterior wall of the clivus was intact with no disruption of the skull
base anatomy.
The standard treatment option, en bloc surgical resection with or
without adjuvant radiationwas offered to the patient.MRI-guided LITT
was offered as an alternative treatment option. The family was
thoroughly counseled that although this approach may be less
disruptive, and require less operative time, the effect of thermal
energy on chordoma cells is not known. The patient and her family
decided to undergo LITT as part of an institutional IRB-approved study.
Intervention
The patient was placed in the supine position under general
anesthesia. The setup was similar to all endoscopic endonasal skull
base cases performed at our institution. A single-nare approach was
utilized. The cooling catheter was introduced into the nose after
passing it through the guidance bolt (Fig. 2A). We achieved excellent
visualization of the exophytic endonasal portion of the mass. A
1.65 mm diameter coaxially-cooled diffusing tip laser applicator
(VCLAS-400, BioTex, Inc., Houston, TX, USA) was then introduced
through the surface of the mass until the bony clivus was felt at the
posterior margin of the mass (Fig. 2B). The plastic guidance bolt
typically used to anchor the laser to the skull was then advanced
down the applicator and seated in the left nostril (Fig. 2C). A 2-0 silk
suture was sewn to the nasal septum and tightly tied to the bolt to
restrict any migration during transport to MRI (Fig. 2D). The blue cap
of the guidance bolt was then screwed tightly over the clear base in
order to secure the laser catheter’s position within the lumen of the
guidance bolt.
The patient was then transferred to theMRI scanner (GE, 1.5 Tesla)
to initiate therapy. The laser applicator tip was connected to the
Visualase Thermal Therapy System (BioTex Inc., Houston, TX, USA),
which provides up to 15 Watts of 980 nm laser energy and software
that allows real- timeMR thermal monitoring of the selectedMR slice.
Oblique sagittal sequences in line with the laser catheter were
obtained and conﬁrmed optimal laser placement. A reference image in
the sagittal plane was selected as the monitoring slice for proton
resonance frequency (PRF) based magnetic resonance temperature
imaging (MRTI) on the Visualase workstation (Fig. 3A). This allows for
temperature information to be superimposed over live treatment
images in real-time (Fig. 3B). Target temperature limits were set to90 °C near the catheter and 50 °C at the posterior and superior
borders of the clivus. Based on the temperature and time history, the
software predicted cell kill, utilizing the Arrhenius damage model. A
test dose was delivered at 3.1 W for 33 s. This conﬁrmed the laser
location within the targeted lesion. Once conﬁrmed, a total of 4
ablations were performed at 12 W for a combined total of 311 s.
Post-ablation MR imaging conﬁrmed that the zone of ablation
encompassed the entire tumor and therapy was concluded. The laser
was removed and post-operative imaging conﬁrmed no hemorrhage
within the nasal cavity. The patient was then transferred to recovery
where she was extubated in stable condition. She was admitted
overnight and discharged the next day without any postoperative
complications. After 4 months, her dysphagia has resolved and she
reports no further voice changes. The patient is being followed closely
with serial imaging.
Results
Radiographic evaluation
Prior to thermal ablation, the lesion heterogeneously enhanced
consistent with viable tumor. There was no edema or hematoma seen
around or within the lesion. Gadolinium enhanced MRI scans were
obtained immediately after ablation, and at various time points after
therapy. All post-ablation scans demonstrate a peripherally enhancing
lesion with a central focus of low signal that encompasses the entire
region of enhancement that was seen on pre-operative MRI. These
ﬁndings are consistent with complete thermal ablation [5]. An MRI
performed at 136 days post-ablation shows a reduction in lesion size.
Volumetric analysis was performed on all images to quantify
changes in the size of the tumor mass. The lesion volume was
estimated by evaluating it as an ellipsoid structure (V = 4/3
π*r1*r2*r3). The tumor lesion diameter was measured in 3 dimensions
based on the largest diameter in axial, coronal, and sagittal planes.
The pre-ablation estimate of the lesion volume was 1.65 cm3. The
immediate post-ablation lesion volume was 2.85 cm3. The lesion
volume at 1 day was 2.47 cm3, at 25 days it was 1.34 cm3, at 73 days
it was 0.59 cm3, and at 136 days the lesion volume was 0.35 cm3.
Ablation dynamics
The Visualase software provides a real-time estimate of thermal
damage area. This information is routinely used to guide the duration
of treatment. The damage estimate is derived from the Arrhenius
equation:
Ω tð Þ ¼
Zl
0
Ae
‐Ea
RT τð Þdτ:
Fig. 2. Endoscopic endonasal insertion of laser catheter. (A) The single-nare endoscopic approach. (B) Chordomawith laser catheter in ﬁnal position. (C) Camera is removed andplastic guidance
bolt is seated in nostril. (D) Stitch is thrown in nasal septum and tied to clear plastic base of guidance bolt. Blue cap is then screwed tight to hold the catheter within the guidance bolt’s lumen.
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respectively. T(τ) is the tissue temperature over time, R is the universal
gas constant, and t is time. In theVisualase software, voxels are assumed
to have reached the threshold for thermal damage whenΩ ≥ 1 and are
displayed in orange (Fig. 4). Once the damage estimate that is
superimposed on the reference image indicates that the entire lesion
has been ablated, treatment is concluded. The number of damage voxels
is converted into damage area (mm2) by the following formula:
Damage area ¼ No: of pixels FOV FOVð Þ= 256 256ð Þ
FOV is the ﬁeld of view; 256 × 256 is the speciﬁed image
acquisition matrix. The ﬁrst ablation for this patient produced an
estimated damage area of 156 mm2. Ablation plateau was reached at
approximately 60 s. The time to reach 50% of the total ablation area
(t½) was 7.4 s (Fig. 5). The subsequent three treatments that were
performed did not signiﬁcantly increase the estimated damage area.
Discussion
Clival chordomas present many challenges to the neurosurgeon.
Complete tumor resection at the skull base may be difﬁcult to achieve.Fig. 3. Real-time MR thermography. (A) Laser catheter (red arrow) within tumor. (Radiation therapy may reduce local recurrence but is associated with
complications such as radiation necrosis, cranial nerve injury, and
pituitary dysfunction. MRI-guided laser induced thermal therapy
(LITT) is a novel treatment modality that has not yet been applied to
chordomas. In this report we demonstrate the safety and technical
feasibility of utilizing MRI-guided LITT for skull base pathologies and
report the responsiveness of a chordoma to thermal energy.
The reduction in lesion volume over time indicates that chordomas
are responsive to thermal ablation and follow a response proﬁle
similar to those of other pathologies. The immediate post- ablation
lesion volume is almost always larger than the pre-ablation volume
due to hyperacute thermal-induced edema [5].
Upon resolution, a steady decline in lesion volume may be
observed for at least 4 months. As a result, LITT may be useful as an
adjunctive treatment or even palliative measure in patients who
require local tumor control but are not operative candidates.
In an effort to guide future ablation procedures, we attempt to
deﬁne parameters deﬁne tumor response to thermal energy. We
propose two parameters: the thermal damage ratio and the thermal
ablation constant.
We deﬁne thermal damage as the ratio of the estimated thermal
damage area to the pre-ablation lesion area based on the referenceB) MR thermography showing the temperature surrounding the laser catheter.
Fig. 4. Estimated damage area. (A) Reference sagittal T1MRI with contrast showing lesion (red arrow) with catheter in place. (B) Voxels that reach the threshold for thermal ablation
are converted to orange and superimposed on live images.
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190 mm2 and estimated thermal damage area of 156 mm2, yielding a
thermal damage ratio is 0.821.
Thermal damage ratio ¼ Thermal damage area estimate
Pre−ablation lesion area
There are certain limitations to this measurement. The pre-
treatment lesion area is calculated from the reference image, which
is an elliptical approximation of the lesion and is susceptible to
overestimation, possibly explaining an underestimation of the
damage ratio. While our damage ratio (0.821) suggests incomplete
ablation, our post-ablation imaging showed complete ablation, also
indicating an overestimation of pre-ablation area. Additionally, an
irregular-shaped tumor volume may also decrease the accuracy of
single-plane estimation. Software upgrades that overcome this
limitation are currently under development.
Thermal ablation dynamics for chordomas have not been previ-
ously reported. To quantify the response, we correlated ablation area
versus time by using the standard logarithm formula A = loga(t),
where A represents ablation damage area, t represents time in
seconds, and a is the thermal ablation constant. When the laser power
is held constant (12 W), the area of ablation increases logarithmically
with duration. Our data suggested a maximum ablation area of
156 mm2. Using our intraoperative data, a can be estimated to be
1.026. This allows us to calculate the predicted ablation area based on
duration (t). This basic regression model ﬁts the observed data with
an R2 of 99.2%. We hypothesize that different lesions have unique
thermal ablation constants. In a chordoma ablated under 12 W ofFig. 5. Estimated damage area versus time. The damage estimate grows rapidly during
the ﬁrst few seconds of ablation then slows considerably. This is consistent with
thermal growth models based on the Arrhenius equation.laser power with a thermal ablation constant of 1.026, the damage
area estimate is:
Damage area ¼ log1:026 tð Þ
Even though more sophisticated regression techniques may
generate a more reﬁned model, we seek to prove our concept with
this simpliﬁed version.
Several conclusionsmay be drawn on the inherent susceptibility of
the tumor to thermal ablation. Variations in vascularity, water content,
density and proximity to ﬂuid collections or bone all affect a particular
tissue’s response to laser ablation. We have attempted to quantify the
overall effect of these variables as the thermal ablation constant.
Theoretically, as the constant approaches 1, the ablation area increases
with shorter ablation times. Therefore, we hypothesize that tumor
thermal ablation constants closer to 1 represent a higher susceptibility
to thermal ablation and a more favorable response to LITT.
The thermal ablation constant also provides physicians with a tool
to calculate laser dosimetry. Knowing a particular tumor’s thermal
ablation constant and area enables a clinician to estimate treatment
time and determine the tumor’s amenability to laser ablation. In a
chordoma with an area of 200 mm2, our model predicts total ablation
with a 12 W laser for approximately 170 s, which are reasonable
operative conditions. However, in a 400 mm2 chordoma, our model
predicts an ablation duration of over 7 h. Our group has shown other
tumors of this size to be easily ablated in signiﬁcantly less time,
suggesting that the current model may be inaccurate for larger
lesions. Additionally, due to the unique anatomy of this particular case
(tumor surrounded by nasopharyngeal air and bone), the tumor may
have been completely ablated when the damage area reached
156 mm2. If the tumor were surrounded by brain tissue, ablation
may have continued, yielding a model that may better account for
larger lesions.
Further studies to evaluate the utility of the thermal ablation
constant are required. Each tumor will have some variability in its
tissue composition and it is unlikely that even two chordomas would
have exactly the same thermal ablation constant. As previously
discussed, variations in the tissue composition of a tumor may change
its response to thermal ablation. We therefore aim only to introduce
the idea to the literature and prompt further investigations into the
dynamic response of various tumors to LITT.
The long-term efﬁcacy of MRI-guided LITT in chordoma treatment
is yet to be established. The short-term results presented in this case
are promising and demonstrated the susceptibility of chordomas to
thermal ablation. Chordomas have high water content and low
vascularity, features that make them ideal targets for thermal
ablation. Our patient also beneﬁted from having a rim of intact clivus,
which may have shielded vital neural structures from unintended
thermal damage. Our technique is minimally invasive with short
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feedback. The possibility of thermal ablation as a primary treatment
option is unknown at this time. Nonetheless, thermal ablation
therapies show potential as an alternative or adjunctive treatment
modality for chordomas.Conclusion
MR-guided LITT is technically feasible for skull-base lesions
permissible to endonasal approaches. Chordoma cells are highly
sensitive and responsive to thermal energy. MR-guided LITT may be a
useful adjunct in select clival chordomas. Longer term follow-up andlarger series will be necessary to determine whether this technique
can improve non-recurrence rates in clival chordomas.
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